Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients
Titel:
Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients
Auteur:
Campone, Mario Rademaker-Lakhai, Jeany M. Bennouna, Jaafar Howell, Stephen B. Nowotnik, David P. Beijnen, Jos H. Schellens, Jan H. M.